We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.30
Ask: 1.40
Change: 0.125 (10.20%)
Spread: 0.10 (7.692%)
Open: 1.225
High: 1.35
Low: 1.20
Prev. Close: 1.225
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Comptoir opens restaurant; Intercede wins contract

Thu, 07th Dec 2023 15:31

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Comptoir Group PLC - Owner and operator of a chain of Lebanese restaurants - Opens new restaurant at the Southbank Centre, London. The restaurant will be located opposite the entrance of the Royal Festival Hall, neighbouring Las Iguanas, Cote Brasserie and Honest Burgers restaurants. Says that with over 5,400 events a year, the Southbank Centre site has a footfall of 19 million a year. Expects to open restaurant around Easter next year. Chief Executive Nick Ayerst says: "Following the successful recent opening in Ealing, we are pleased to announce the continued strategic growth in an area of London we have long desired to be in. The location on the South Bank captures an immensely high footfall of both workers, visitors and tourists who we know will be hungry for our well-loved authentic Middle Eastern food and culture."

----------

Intercede Group PLC - Lutterworth, England-based cybersecurity software - Wins a professional services order to help deploy MyID Credential Management Solution to "large US Federal Agency." Says it is the same customer which it won a contract with on Tuesday. Says additional order, worth USD800,000, underpins the company's upgraded financial 2024 and 2025 forecasts. "Once again, I am pleased to announce a further order that supports our upgraded forecasts for FY24 and FY25. This is a testament of the hard work my colleagues have done and indeed continue to do so," says CEO Klaas van der Leest. On Tuesday, Intercede said it signed a "major" new contract with the unnamed large US federal agency, with purchase orders received of perpetual licences worth around USD6.6 million. Due to the order, the company expects its financial year 2024 results to be "significantly ahead of market expectations," which it says are a revenue of GBP13.7 million and adjusted earnings before interest, tax, depreciation and amortisation of GBP1.8 million.

----------

Datalex PLC - Dublin-based software company, which specialises in digital retail technology for the airline market - Announces the go live of its Datalex Merchandiser product with easyJet PLC, a Luton Airport-based low-cost airline. Says easyJet is set to begin its migration to Datalex Direct and Datalex Dynamic in 2024 to drive next generation retailing and an improved booking experience. Chief Revenue Officer Bryan Porter says: "We are proud to be partnering with easyJet to drive forward the airline's digital retail strategy, supporting high value revenue growth and enhancing the exceptional customer experience for easyJet's customers. The recent go live is a major milestone in our journey, and we look forward to continuing to provide the airline with superior and innovative digital retailing capabilities that will enable them to deliver new, revenue generating and differentiated customer experiences."

----------

Wynnstay Properties PLC - Powys, Wales-based agricultural and specialist merchanting firm - Exchanges contracts for the acquisition from three members of the Gunne family of Units 1-4, 18a Wildmere Road, Banbury, and Unit 14, The IO Centre, Whittle Way, Stevenage, for GBP2.5 million in total. The Banbury property is freehold and comprises two industrial buildings, separately let to established national and regional trade counter businesses, with service yards and an access road. The total rent passing is GBP103,425 per year. The Stevenage Property is held on a 999-year lease at a nominal rent and comprises a mid-terrace industrial unit. The rent passing on the single occupational sub-lease to an established national trade counter business is GBP57,550 per annum. The acquisition in expected to complete at the beginning of 2024. Chris Betts, Managing Director of Wynnstay, says: "The acquisition of these highly accessible and well-let properties broadens the geographic spread of Wynnstay's portfolio and enhances our focus on the growth potential of the light industrial/trade counter warehouse sector."

----------

Develop North PLC - investor in residential and commercial property sector advised by Newcastle, England-based Tier One Capital Ltd - Extends share buyback programme. Says it will repurchase up to a further GBP500,000. The programme will end December 31. The purchased shares will be held in treasury.

----------

Eqtec PLC - Thermochemical conversion technology company - Signs an equipment supply agreement for engineering services and equipment supply for a plant in Wilseyville, California, US. The plant is being developed to cleanly convert approximately 25,000 tonnes per year of wood waste into synthesis gas to fuel a gas engine coupled to alternators for production of about 3.0 MWe electricity. The Agreement is with Blue Mountain Electric Company LLC, a project company set up and operated by Phoenix Biomass Energy Inc. Expects to commence basic engineering work in early 2024 and to invoice about USD330,000 for this work, which the company expects to complete in the first half of 2024.

----------

Videndum PLC - London-based manufacturer of hardware and software for the content creation market, including broadcasters and film studios - Raises GBP125 million through placing and open offer. Raises GBP75 million through placing of 28.1 million shares and GBP50 million through open offer of 18.7 million shares. CEO Stephen Bird says: "We are pleased with the very strong response to the capital raising and I would like to thank both our shareholders and new investors for their support. We now have a robust capital base which will enable Videndum to focus its resources on strategic execution and long-term value creation for shareholders through our market-leading, premium brands which are focused on the content creation market."

----------

Shield Therapeutics PLC - Commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Updates shareholders on third quarter US commercial highlights. Total prescriptions reach over 27,750, up 76% from the second quarter. Notes US third quarter net revenue of USD4.1 million. CEO Greg Madison comments: "Shield continues to make excellent progress on the US commercial launch of Accrufer. As we approach the one-year anniversary of the announcement of the Viatris agreement, I am pleased to report that the collaboration continues to deliver excellent results, based on the stand-out performance of the combined commercial team, which has produced consistent and strong sequential prescription growth and key performance indicators, which are trending towards previous guidance."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Apr 2024 14:26

UK earnings, trading statements calendar - next 7 days

Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Quilter PLCQ1 Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Whitbread PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
21 Feb 2024 16:57

LONDON MARKET CLOSE: FTSE 100 takes hit ahead of FOMC minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors anxiously look ahead to this evening's Federal Open Market Committee meeting minutes.

Read more
21 Feb 2024 12:36

Shield Therapeutics sinks as strong performance marred by data issues

(Alliance News) - Shield Therapeutics PLC on Wednesday said that it was expecting stellar results for 2023, but this success was overshadowed by a mistake in the company's previous prescription forecasts.

Read more
9 Jan 2024 11:33

IN BRIEF: Shield Therapeutics hires former Akili leader as new CFO

Shield Therapeutics PLC - Commercial-stage pharmaceutical company focused on iron deficiency product Accrufer - Hires Santosh Shanbhag as chief financial officer, effective next Tuesday. He replaces Hans-Peter Rudolf, who left Shield in October to pursue new opportunities. Shanbhag was previously CFO of Nasdaq-listed Akili Inc, which he "helped transform...from a private to a public entity". Before this, he held various senior finance leadership roles at Vertex Pharmaceuticals Inc, including as Head of International Finance & Accounting.

Read more
7 Dec 2023 13:11

Shield Therapeutics reports strong US progress

(Sharecast News) - Iron deficiency-focussed pharmaceuticals company Shield Therapeutics announced significant achievements in the US commercialisation of Accrufer on Thursday.

Read more
12 Oct 2023 11:14

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

Shield Therapeutics PLC - commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Chief Financial Officer Hans-Peter Rudolf will leave the company next week Friday to pursue other opportunities. The firm's company controller, Paul Spoors, will take on the CFO role on an interim basis. Shield says it has engaged an executive search firm to identify a new CFO.

Read more
12 Oct 2023 10:27

AIM WINNERS & LOSERS: Windward sees high contracting activity levels

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
3 Oct 2023 17:14

TRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
3 Oct 2023 14:29

Shield Therapeutics completes USD20 million SWK financing

(Alliance News) - Shield Therapeutics PLC on Tuesday said it has now completed its USD20 million senior secured debt facility from SWK Funding LLC.

Read more
28 Sep 2023 14:54

UPDATE: Shield Therapeutics completes GBP5 million share placing

(Alliance News) - Shield Therapeutics PLC on Thursday announced steps to improve its financial situation, as it revealed a slightly reduced loss in the first half of 2023.

Read more
28 Sep 2023 11:30

Shield Therapeutics raises funds for US sales push as loss narrows

(Alliance News) - Shield Therapeutics PLC on Thursday announced steps to improve its financial situation, as it revealed a slightly reduced loss in the first half of 2023.

Read more
21 Sep 2023 15:48

UK earnings, trading statements calendar - next 7 days

Friday 22 September 
Ascential PLCHalf Year Results
Ergomed PLCHalf Year Results
First Tin PLCHalf Year Results
t42 IoT Tracking Solutions PLCHalf Year Results
t42 IoT Tracking Solutions PLCTrading Statement
Monday 25 September 
Alphawave IP Group PLCHalf Year Results
Devolver Digital IncHalf Year Results
Dialight PLCHalf Year Results
Getech Group PLCHalf Year Results
Ondine Biomedical IncHalf Year Results
Real Estate Investors PLCHalf Year Results
SpaceandPeople PLCHalf Year Results
Spectra Systems CorpHalf Year Results
Transense Technologies PLCFull Year Results
Venture Life Group PLCHalf Year Results
Wilmington PLCFull Year Results
Tuesday 26 September 
Alliance Pharma PLCHalf Year Results
AG Barr PLCHalf Year Results
Animalcare Group PLCHalf Year Results
Asos PLCTrading Statement
Boku IncHalf Year Results
Card Factory PLCHalf Year Results
Cambridge Cognition Holdings PLCHalf Year Results
Close Brothers Group PLCFull Year Results
Diaceutics PLCHalf Year Results
DigitalBox PLCHalf Year Results
Dillistone Group PLCHalf Year Results
EKF Diagnostics Holdings PLCHalf Year Results
Ferguson PLCFull Year Results
Finsbury Food Group PLCFull Year Results
IQGeo Group PLCHalf Year Results
Learning Technologies Group PLCHalf Year Results
LifeSafe Holdings PLCHalf Year Results
Mission Group PLCHalf Year Results
Mortgage Advice Bureau Holdings PLCHalf Year Results
NAHL Group PLCHalf Year Results
Next 15 Group PLCHalf Year Results
Newmark Security PLCFull Year Results
NIOX Group PLCHalf Year Results
Origin Enterprises PLCFull Year Results
PZ Cussons PLCFull Year Results
Safestay PLCHalf Year Results
Smiths Group PLCFull Year Results
Time Finance PLCFull Year Results
tinyBuild IncHalf Year Results
Wentworth Resources PLCHalf Year Results
Yu Group PLCHalf Year Results
Wednesday 27 September 
Amicorp FS (UK) PLCHalf Year Results
Aquila European Renewables PLCHalf Year Results
Arix Bioscience PLCHalf Year Results
Avingtrans PLCFull Year Results
Bens Creek Group PLCFull Year Results
Biome Technologies PLCHalf Year Results
BioPharma Credit PLCHalf Year Results
Chapel Down Group PLCHalf Year Results
Everyman Media Group PLCHalf Year Results
Fadel Partners IncHalf Year Results
NCC Group PLCFull Year Results
Old Mutual LtdHalf Year Results
Pantheon Infrastructure PLCHalf Year Results
Pendragon PLCFull Year Results
Plant Health Care PLCHalf Year Results
Safestyle UK PLCHalf Year Results
Saga PLCHalf Year Results
Skillcast Group PLCHalf Year Results
Surface Transforms PLCHalf Year Results
Xeros Technology Group PLCHalf Year Results
Zinc Media Group PLCHalf Year Results
Thursday 28 September 
Atlantic Lithium LtdFull Year Results
Avacta Group PLCHalf Year Results
Avation PLCFull Year Results
Celadon Pharmaceuticals PLCHalf Year Results
Ceres Power Holdings PLCHalf Year Results
Dar Global PLCHalf Year Results
eEnergy Group PLCFull Year Results
HSS Hire Group PLCHalf Year Results
Microlise Group PLCFull Year Results
Novacyt SAHalf Year Results
Phoenix Spree Deutschland LtdHalf Year Results
RBG Holdings PLCHalf Year Results
Shield Therapeutics PLCHalf Year Results
Silver Bullet Data Services Group PLCHalf Year Results
Trellus Health PLCHalf Year Results
Trinity Exploration & Production PLCHalf Year Results
XLMedia PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
6 Sep 2023 20:33

IN BRIEF: Shield Therapeutics changes reporting currency to US dollars

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Says it will change reporting currency to US dollars from pound sterling from 2023 results. Says the interim results for the first half of 2023 will include condensed and consolidated US dollar financial information for the period and full-year 2022.

Read more
6 Aug 2023 17:07

CORRECT: Biogens, Sage Therapeutics postpartum depression drug okayed

(Correcting the name of Sage Therapeutics Inc. Please ignore incorrect coding of Shield Therapeutics PLC.)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.